Solid-Phase Total Synthesis of Plusbacin A<sub>3</sub>-Reference-Cited by-同舟云学术

Solid-Phase Total Synthesis of Plusbacin A₃

Published:2022-03-16 Issue:11 Volume:24 Page:2253-2257
ISSN:1523-7060
Container-title:Organic Letters
language:en
Short-container-title:Org. Lett.

Author:

Takashina Kazuki¹^ORCID,Katsuyama Akira¹²³^ORCID,Kaguchi Rintaro¹^ORCID,Yamamoto Kazuki¹²^ORCID,Sato Toyotaka⁴⁵,Takahashi Satoshi⁶⁷,Horiuchi Motohiro⁴⁵,Yokota Shin-ichi⁸,Ichikawa Satoshi¹²³^ORCID

Affiliation:

1. Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan

2. Center for Research and Education on Drug Discovery, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan

3. Global Station for Biosurfaces and Drug Discovery, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan

4. Faculty of Veterinary Medicine, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo 060-0818, Japan

5. Graduate School of Infectious Diseases, Hokkaido University, Kita-18, Nishi-9, Kita-ku, Sapporo 060-0818, Japan

6. Division of Laboratory Medicine, Sapporo Medical University Hospital, Minami-1, Nishi-16, Chuo-ku, Sapporo 060-8543, Japan

7. Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Minami-1, Nishi-16, Chuo-ku, Sapporo 060-8543, Japan

8. Department of Microbiology, Sapporo Medical University School of Medicine, Minami-1, Nishi-17, Chuo-ku, Sapporo 060-8556, Japan

Funder

Takeda Science Foundation

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Japan Science and Technology Agency

North Tech Foundation

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.2c00667

Reference45 articles.

1. Antibiotic Resistance Threats in the United States, 2019 (Department of Health and Human Services, CDC, 2019); www.cdc.gov/DrugResistance/Biggest-Threats.html, accessed February 4, 2022.

2. Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4.

3. Structures of new peptide antibiotics, plusbacins A1-A4 and B1-B4.

4. Katanosin B and Plusbacin A 3 , Inhibitors of Peptidoglycan Synthesis in Methicillin-Resistant Staphylococcus aureus

5. The Isotridecanyl Side Chain of Plusbacin-A3 Is Essential for the Transglycosylase Inhibition of Peptidoglycan Biosynthesis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship Studies of the Peptide Antibiotic Clovibactin;The Journal of Organic Chemistry;2024-08-23

2. Advances of Ugi reaction in natural product synthesis;Green Synthesis and Catalysis;2024-08

3. Three‐Component 1,4‐Addition through Ugi‐Type Reaction, an Oxidative Dearomatization Strategy;Asian Journal of Organic Chemistry;2023-12-27

4. Development and Challenges of Cyclic Peptides for Immunomodulation;Current Protein & Peptide Science;2023-11-21

5. Solid-Phase Total Synthesis of Sandramycin and Its Analogues;Organic Letters;2023-01-18